Home AstraZeneca And Isis Pharmaceuticals To Discover And Develop Antisense Drugs For Cardiovascular, Metabolic And Renal Diseases
 

Keywords :   


AstraZeneca And Isis Pharmaceuticals To Discover And Develop Antisense Drugs For Cardiovascular, Metabolic And Renal Diseases

2015-08-04 03:27:28| drugdiscoveryonline News Articles

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) and AstraZeneca today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases.

Tags: develop discover drugs diseases

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Remnants of Fourteen-E Graphics
07.11Remnants of Fourteen-E Forecast Discussion Number 6
07.11Remnants of Fourteen-E Wind Speed Probabilities Number 6
07.11Remnants of Fourteen-E Public Advisory Number 6
07.11Summary for Remnants of Fourteen-E (EP4/EP142024)
07.11Remnants of Fourteen-E Forecast Advisory Number 6
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Advisory Number 17
More »